United Kingdom · Seed startup

Who invested in PharmEnable

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$7.5Mraised across 1 round since 2023, from 1 source

Latest round
Seed, $7.5MMay 2023
Investors
1
See who backed them

The rounds

  1. May 2023
    Seed$7.5M

    Source recorded

Founders and team

From PharmEnable's own website: 3 founders, 2 on the team.

Dr Natalia MateuCEO, Co-Founder & Board of Directors
Jeffrey MooreCEO, Co-Founder & Board of Directors
Dr David VidalCOO & Co-Founder
  • Dr Hannah SoreCTO
  • Dr Keith BlundyChair & Non-Executive Director

AdvisersDr Peter CharltonLenny DangProf Jackie Hunter

Everyone who backed them

ParkwalkVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list PharmEnable as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Martlet CapitalVC firmPer its own site
Meltwind AdvisoryVC firmPer its own site

Quick answers about PharmEnable

Who invested in PharmEnable?

PharmEnable's investors include Parkwalk.

How much has PharmEnable raised?

PharmEnable has raised $7.5M across 1 round since 2023.

When did PharmEnable last raise?

PharmEnable's most recent round was a Seed of $7.5M in May 2023.

What was PharmEnable's biggest round?

Its most recent round, $7.5M in May 2023, is also its largest on record.

Who backed PharmEnable first?

PharmEnable's first round on record, in May 2023, was backed by Parkwalk.

What stage is PharmEnable at?

PharmEnable's latest named round is a Seed, in May 2023.

Where is PharmEnable based?

PharmEnable is based in the United Kingdom.

Companies like PharmEnable

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.